LA JOLLA INSTITUTE FOR IMMUNOLOGY
LA JOLLA, California
Total Received
$340.5M
Total Awards
64
State
California
Last Updated
Mar 24, 2026
Yearly Funding Trend
$304.2M24
$31.5M25
$4.8M26
Top 50 Awards to LA JOLLA INSTITUTE FOR IMMUNOLOGY
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 24, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_U19AI142790_075 CONSORTIUM FOR IMMUNOTHERAPEUTICS AGAINST EMERGING VIRAL THREATS - SUMMARY: OVERALL THIS PROPOSAL, CONSORTIUM FOR IMMUNOTHERAPEUTICS AGAINST EMERGING VIRAL DISEASES, ADDRESSES A… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $39,996,672 |
ASST_NON_U19AI118626_075 RESPIRATORY PATHOGEN-SPECIFIC T CELL SIGNATURES FOLLOWING VACCINATION, NATURAL INFECTION, AND TREATMENT - PROJECT SUMMARY – OVERALL THE LA JOLLA HIPC TEAM WILL FOCUS ON PATHOGENS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $32,004,981 |
ASST_NON_AY1AX000055_075 STRATEGIC HERPESVIRUS IMMUNE EVASION AND LATENCY DEFENSE (SHIELD) | Department of Health and Human Services National Institutes of Health | 93.384 ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) | CA-90 | 2024 | $31,104,137 |
ASST_NON_U19AI142742_075 HUMAN IMMUNE MEMORY TO COVID-19, VACCINES, AND RESPIRATORY PATHOGENS - OVERALL COMPONENT SUMMARY OUR LJI CCHI WAS FIRST FUNDED IN APRIL OF 2019 AND HAS BEEN HIGHLY IMPACTFUL IN HU… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $27,693,416 |
CONT_AWD_75N93019C00001_7529_-NONE-_-NONE- IMMUNE EPITOPE AND ANALYSIS PROGRAM (IEDB) | Department of Health and Human Services National Institutes of Health | — | LA JOLLA, CA-50 | 2024 | $24,260,098 |
ASST_NON_U01AI167892_075 HIPC DATA COORDINATING CENTER - PROJECT SUMMARY/ABSTRACT THE HUMAN IMMUNOLOGY PROJECT CONSORTIUM (HIPC) WAS FOUNDED IN 2010 TO CREATE A NETWORK OF INDEPENDENT CENTERS FOCUSED ON M… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $14,760,228 |
ASST_NON_R24AI108564_075 RESEARCH RESOURCES: EPIGENOMIC AND TRANSCRIPTOMIC PROFILE OF HUMAN IMMUNE CELLS - PROJECT SUMMARY WHILE AN ENORMOUS NUMBER OF GENETIC VARIANTS HAVE BEEN ASSOCIATED WITH RISK FOR H… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2025 | $10,844,192 |
ASST_NON_R01AI040127_075 SIGNAL TRANSDUCTION AND GENE INDUCTION IN LYMPHOCYTES - ABSTRACT MODERN IMMUNOTHERAPIES HAVE HAD A BROAD IMPACT IN CLINICAL ONCOLOGY. CAR T CELL THERAPY HAS BEEN DRAMATICALLY SUCC… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $9,708,046 |
ASST_NON_R35CA210043_075 THE TET-DNMT-ASXL1-OGT AXIS: RELEVANCE TO CLONAL HEMATOPOIESIS, HETEROCHROMATIN INTEGRITY AND CANCER - ABSTRACT DURING THE PREVIOUS FUNDING PERIOD, WE MADE IMPORTANT STRIDES IN AN… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | LA JOLLA, CA-50 | 2024 | $9,486,061 |
ASST_NON_R01HL114093_075 EPIGENETICS OF SEVERE ASTHMA - PROJECT SUMMARY IN THIS MULTI-PI PROPOSAL WE WILL INVESTIGATE THE ROLE OF EPIGENETIC MECHANISMS IN DRIVING SEVERE ASTHMA PATHOGENESIS. THE IDENTIFIC… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $8,533,700 |
ASST_NON_R01AI109842_075 NFAT, BZIP PROTEINS, AND TRANSCRIPTIONAL PROGRAMS IN LYMPHOCYTES - ABSTRACT BLOCKING ANTIBODIES TO CTLA4, PD-1, AND OTHER INHIBITORY SURFACE RECEPTORS EXPRESSED ON EXHAUSTED T CEL… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $7,875,045 |
ASST_NON_U01AI150753_075 DEVELOPING COMPUTATIONAL MODELS TO PREDICT THE IMMUNE RESPONSE TO B. PERTUSSIS BOOSTER VACCINATION - PROJECT SUMMARY/ABSTRACT: BORDETELLA PERTUSSIS (PT) IS THE CAUSATIVE AGENT OF… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $7,067,633 |
ASST_NON_U19AI135731_075 LJI EPITOPE VALIDATION CENTER: CHARACTERIZATION OF EPITOPE-SPECIFIC T CELLS RESPONDING TO FOOD, FUNGAL AND INNER CITY ALLERGENS - CENTER PROGRAM SUMMARY/ABSTRACT OUR PROPOSAL WILL… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $5,577,282 |
ASST_NON_R01AI128589_075 INVESTIGATING THE ROLE OF TET DEFICIENCY IN PROMOTING T CELL EXPANSION AND INFLAMMATION - ABSTRACT DNA CYTOSINE METHYLATION (HEREAFTER, DNA METHYLATION) HAS A CRITICAL ROLE IN CEL… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $5,305,237 |
ASST_NON_R01AI101423_075 THE ROLE OF TRAIL IN IMMUNE CONTROL OF CYTOMEGALOVIRUS - SUMMARY CYTOMEGALOVIRUS (CMV, A B-HERPESVIRUS) ESTABLISHES A PERSISTENT INFECTION THAT IS ENDEMIC IN HUMANS AND MICE. CMV… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2025 | $4,635,949 |
ASST_NON_U01DE028227_075 STIMULATING NEO-ANTIGEN SPECIFIC T CELL RESPONSES IN HEAD AND NECK CANCERS - ABSTRACT NEOANTIGENS (NEOAG) OFFER A UNIQUE AND POWERFUL OPPORTUNITY FOR DIRECTING A PATIENT’S IMMUNE… | Department of Health and Human Services National Institutes of Health | 93.121 ORAL DISEASES AND DISORDERS RESEARCH | LA JOLLA, CA-50 | 2025 | $4,612,680 |
ASST_NON_U24CA248138_075 THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE - ABSTRACT RECENT YEARS HAVE WITNESSED A DRAMATIC RISE IN INTEREST TOWARDS CANCER EPITOPES IN GENERAL, AND NEOEPITOPES THAT ENCOM… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | LA JOLLA, CA-50 | 2024 | $4,550,196 |
ASST_NON_R37AI125068_075 MAXIMIZING GERMINAL CENTERS AND SOMATIC HYPERMUTATION TO HIV ENV IMMUNOGENS - ABSTRACT WE PROPOSE THAT THE FEATURES OF GERMINAL CENTER BIOLOGY IMPORTANT FOR DEVELOPING HIGH AFFINI… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $4,431,323 |
ASST_NON_R01AI125068_075 MAXIMIZING GERMINAL CENTERS AND SOMATIC HYPERMUTATION TO HIV ENV IMMUNOGENS - DESCRIPTION (PROVIDED BY APPLICANT): FOLLICULAR HELPER T CELLS (TFH) ARE THE SPECIALIZED CD4 T C… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2025 | $4,303,074 |
ASST_NON_U01AI141995_075 IDENTIFYING MECHANISMS AND CORRELATES OF LONG-LASTING VACCINE-INDUCED IMMUNITY TO WHOOPING COUGH - PROJECT SUMMARY/ABSTRACT RECENT YEARS WITNESSED A WORLDWIDE REEMERGENCE OF PERTU… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $4,115,635 |
ASST_NON_R35GM128938_075 STUDYING THE FUNCTION OF HUMAN GENETIC VARIATION IN THE LIGHT OF 3D GENOME ORGANIZATION - ABSTRACT THE SEARCH FOR CAUSAL GENETIC VARIANTS ASSOCIATED WITH SPECIFIC DISEASES AMONG M… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | LA JOLLA, CA-50 | 2024 | $4,076,468 |
ASST_NON_R01AI121426_075 EPIGENOME-WIDE ASSOCIATION STUDY OF CHILDHOOD ASTHMA - PROJECT SUMMARY IN THIS MULTI-PI PROPOSAL WE WILL INVESTIGATE THE ROLE OF EPIGENETIC MECHANISMS IN THE DEVELOPMENT OF ASTHMA… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $3,919,897 |
ASST_NON_U01CA260588_075 SARS-COV-2-REACTIVE TISSUE-RESIDENT MEMORY T CELLS IN HEALTHY AND CANCER SUBJECTS - PROJECT SUMMARY THIS MULTI-PI PROPOSAL TITLED “SARS-COV-2-REACTIVE SUBJECTS” IS WRITTEN IN RESP… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | LA JOLLA, CA-50 | 2024 | $3,602,121 |
ASST_NON_R01AI163188_075 DEVELOPMENT OF A REPLICON RNA-BASED VACCINE AGAINST DENGUE AND ZIKA - ABSTRACT THE LONG-TERM GOAL OF THIS PROJECT IS TO DEVELOP A DENGUE-ZIKA VACCINE THAT PROVIDES PROTECTION AGAI… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $3,590,945 |
ASST_NON_R01CA256133_075 BIOACTIVE METABOLITES MODULATE IMMUNE-RELATED ADVERSE EVENTS IN CANCER IMMUNOTHERAPY - PROJECT SUMMARY IMMUNE CHECKPOINT BLOCKADE (ICB) THERAPY HAS DEMONSTRATED SIGNIFICANT CLINIC… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | LA JOLLA, CA-50 | 2024 | $3,549,010 |
ASST_NON_R01AI134971_075 INTEGRATED FUNCTIONAL HISTOPATHOLOGY OF THE DIABETIC HUMAN PANCREAS - ABSTRACT TYPE 1 DIABETES (T1D) IS A MAJOR AUTOIMMUNE DISEASE THAT POSES SIGNIFICANT PROBLEMS TO AFFLICTED IN… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $3,515,000 |
ASST_NON_R01AI143934_075 THE ROLE OF CYTOPLASMIC AND NUCLEAR THEMIS IN IMMATURE AND MATURE T CELLS - ABSTRACT THEMIS ASSOCIATES WITH A GROWING NUMBER OF INFLAMMATORY DISEASES IN HUMANS, INCLUDING CELIAC D… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $3,442,230 |
ASST_NON_R01AI139749_075 CD4 T CELL CONTROL OF CYTOMEGALOVIRUS - SUMMARY CYTOMEGALOVIRUS (CMV, A B-HERPESVIRUS) ESTABLISHES A PERSISTENT INFECTION THAT IS ENDEMIC IN HUMANS AND MICE. CMV CAUSES ACUTE CLIN… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2025 | $3,237,097 |
ASST_NON_R01AI153500_075 MATERNAL ANTIBODY-MEDIATED ENHANCEMENT OF DENGUE PATHOGENESIS - ABSTRACT DENGUE VIRUS (DENV) REPRESENTS A MAJOR THREAT TO GLOBAL HEALTH. HOWEVER, THE PRECISE ROLE OF THE IMMUNE SY… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $3,138,902 |
ASST_NON_R01AI137230_075 HOST NUTRIENTS PERMIT IMMUNE EVASION OF NKT CELL ANTI-BACTERIAL RESPONSES - SUMMARY INVARIANT NATURAL KILLER T CELLS (INKT CELLS) EXPRESS AN INVARIANT TCR Α CHAIN AND THEY CAN… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $3,076,945 |
ASST_NON_T32AI125179_075 TRAINING IN IMMUNOLOGICAL MECHANISMS - THIS PROGRAM WILL TRAIN POSTDOCTORAL RESEARCH SCIENTISTS IN IMMUNOLOGICAL MECHANISMS RELATED TO UNDERSTANDING HOW AUTOIMMUNE, INFLAMMATORY,… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $3,054,987 |
CONT_AWD_75N93026C00001_7529_-NONE-_-NONE- IMMUNE EPITOPE DATABASE AND ANALYSIS PROGRAM | Department of Health and Human Services National Institutes of Health | — | LA JOLLA, CA-50 | 2026 | $2,826,859 |
ASST_NON_R01CA247500_075 EXPLORING THE POTENTIAL OF TET INHIBITION IN CANCER IMMUNOTHERAPY - ABSTRACT. THE GOAL OF CANCER IMMUNOTHERAPY IS TO HARNESS THE IMMUNE SYSTEM TO DESTROY TUMORS IN CANCER PATIENTS… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | LA JOLLA, CA-50 | 2024 | $2,671,844 |
ASST_NON_R01CA233862_075 A TREG CELL-INTRINSIC CTLA4-PKC-ETA SIGNALING PATHWAY MEDIATING CONTACT-DEPENDENT SUPPRESSION OF TUMOR IMMUNITY: A NOVEL TARGET FOR CANCER IMMUNOTHERAPY - ABSTRACT REGULATORY T CE… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | LA JOLLA, CA-50 | 2024 | $2,594,391 |
ASST_NON_R01AI146042_075 HISTAMINE-RELEASING FACTOR OLIGOMERS IN FOOD ALLERGY - PROJECT SUMMARY THE PREVALENCE OF FOOD ALLERGY HAS BEEN DRAMATICALLY INCREASING FOR THE LAST FEW DECADES. ALTHOUGH STUDIES U… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $2,537,324 |
ASST_NON_U01AI187062_075 TOWARDS A PREDICTIVE UNDERSTANDING OF INFLUENZA IMMUNITY THROUGH EXPERIMENTAL DATA INTEGRATION, ITERATIVE MODEL DEVELOPMENT, AND RIGOROUS ASSESSMENT OF MODEL QUALITY - PROJECT SUM… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2025 | $2,493,234 |
ASST_NON_R01AI135193_075 CD4 T CELL, GERMINAL CENTER, AND ANTIBODY RESPONSE DEFECTS IN RECURRENT TONSILLITIS - PROJECT SUMMARY IT HAS REMAINED A LONGSTANDING MYSTERY WHY SOME CHILDREN ARE SUSCEPTIBLE TO R… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $2,250,000 |
CONT_AWD_75N93024C00056_7529_-NONE-_-NONE- EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI MODIFICATION TO DESCOPE THE IDENTIFICATION AND VALIDATION OF… | Department of Health and Human Services National Institutes of Health | — | LA JOLLA, CA-50 | 2024 | $2,080,465 |
CONT_AWD_75N93024C00057_7529_-NONE-_-NONE- EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI MODIFICATION TO DESCOPE IDENTIFICATION AND CHARACTERIZATION O… | Department of Health and Human Services National Institutes of Health | — | LA JOLLA, CA-50 | 2024 | $2,079,792 |
ASST_NON_R01AR072640_075 TWEAK AND SKIN INFLAMMATION - ABSTRACT SKIN INFLAMMATORY DISEASES, SUCH AS ATOPIC DERMATITIS AND PSORIASIS, ARE THOUGHT TO BE DRIVEN BY THE INTERPLAY BETWEEN THE IMMUNE SYSTEM AND… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $1,964,160 |
ASST_NON_U01AI180152_075 DYSREGULATION OF TET DIOXYGENASE FUNCTION AS A SOURCE OF ABERRANT TRANSPOSABLE ELEMENT EXPRESSION DURING HUMAN AGING - ABSTRACT IT IS WELL ESTABLISHED THAT AGING IS ACCOMPANIED BY… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $1,956,637 |
ASST_NON_R35GM147554_075 ELUCIDATING THE SIGNALING AND PROTEIN INTERACTION NETWORKS OF THE O-GLCNAC TRANSFERASE DURING EMBRYONIC STEM CELL STATE TRANSITIONS - PROJECT SUMMARY/ABSTRACT O-GLCNAC IS A SINGLE… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | LA JOLLA, CA-50 | 2024 | $1,919,433 |
ASST_NON_R01AI180196_075 A NOVEL STRATEGY FOR VACCINE-INDUCED PROTECTION AGAINST MATERNAL-TO-FETAL TRANSMISSION OF ZIKA VIRUS - PROJECT SUMMARY THE LONG-TERM GOAL OF THIS PROJECT IS TO DEVELOP A VACCINE T… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $1,768,228 |
ASST_NON_R61AI183471_075 HIV MRNA VACCINE STRATEGIES FOR EFFICIENT PRIMING, DIVERSITY AND DURABILITY OF IMMUNE RESPONSES - SUMMARY CONVENTIONAL VACCINE STRATEGIES HAVE NOT INDUCED SUCCESSFUL PROTECTION TO… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $1,767,184 |
ASST_NON_R01CA279795_075 PROTEOME-WIDE BASE EDITOR SCREENS TO ASSESS PHOSPHORYLATION SITE FUNCTIONALITY IN IMMUNOSENESCENCE - ABSTRACT WE OFTEN DEPICT SIGNALING PATHWAYS BY A DOZEN OR SO LANDMARK PHOSPHOR… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | LA JOLLA, CA-50 | 2024 | $1,643,594 |
ASST_NON_R01DK135683_075 GENETIC STUDIES LINKING LSP1 FUNCTION IN T CELLS TO INFLAMMATORY BOWEL DISEASE - PROJECT SUMMARY/ABSTRACT INFLAMMATORY BOWEL DISEASES (IBD) CAUSE SUBSTANTIAL MORTALITY AND MORBIDI… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | LA JOLLA, CA-50 | 2024 | $1,554,036 |
CONT_AWD_75D30122C15481_7523_-NONE-_-NONE- BAA TOPIC 22.3 - SYSTEMIC ASSESSMENT OF IMMUNITY TO B.PERTUSSIS USING VALIDATED ASSAYS&DATA INTEGRATION; MOD01-COR CHANGE | Department of Health and Human Services Centers for Disease Control and Prevention | — | LA JOLLA, CA-50 | 2024 | $1,049,692 |
ASST_NON_R01AI189589_075 ILLUMINATING IMMUNOREGULATORY MECHANISMS OF INTERLEUKIN-1 RECEPTOR 8 AND NOVEL THERAPEUTIC STRATEGIES - PROJECT SUMMARY AS A KEY IMMUNE RESPONSE, INFLAMMATION UNITES INNATE AND AD… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2026 | $890,877 |
ASST_NON_R24OD038114_075 NEXT GENERATION CRISPR READY, HLA CLASS I AND II TRANSGENIC MOUSE PLATFORM - ABSTRACT T CELL RESPONSES ARE CRITICAL IN THE PATHOGENESIS, PREVENTION, AND TREATMENT OF A BROAD RANGE… | Department of Health and Human Services National Institutes of Health | 93.351 RESEARCH INFRASTRUCTURE PROGRAMS | LA JOLLA, CA-50 | 2025 | $775,888 |
ASST_NON_R21AI188119_075 DEORPHANIZING A NOVEL GPCR EXPRESSED BY TISSUE RESIDENT MEMORY CELLS - PROJECT SUMMARY LUNG INFECTIONS REMAIN A SIGNIFICANT SOURCE OF MORBIDITY AND MORTALITY ACROSS ALL AGE GROUPS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2026 | $566,875 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Funding Agencies
View All→Federal Programs (CFDA)
View All→12345678910
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$224.2M
93.384 — ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)$31.1M
93.396 — CANCER BIOLOGY RESEARCH$11.5M
93.393 — CANCER CAUSE AND PREVENTION RESEARCH$9.5M
93.837 — CARDIOVASCULAR DISEASES RESEARCH$8.5M
93.859 — BIOMEDICAL RESEARCH AND RESEARCH TRAINING$6.0M
93.121 — ORAL DISEASES AND DISORDERS RESEARCH$4.6M
93.310 — TRANS-NIH RESEARCH SUPPORT$4.0M
93.395 — CANCER TREATMENT RESEARCH$3.5M
93.846 — ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH$2.0M
Source: USAspending.gov · All Recipients · California